Michigan State University/Breslin Cancer Center — Lansing, Michigan

Michigan State University/Breslin Cancer Center is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 49/100 (POOR). This profile has not yet been claimed by the site owner.

Michigan State University/Breslin Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 49/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan State University/Breslin Cancer Center?

Michigan State University/Breslin Cancer Center has a Crixeo Trust Score of 49/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan State University/Breslin Cancer Center conducted?

Michigan State University/Breslin Cancer Center has 2 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is Michigan State University/Breslin Cancer Center accredited by Crixeo Health?

Michigan State University/Breslin Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan State University/Breslin Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.